By now most readers will have seen the article in Friday’s New York Times discussing Kamakahi v. ASRM, the egg donor price fixing litigation that I’ve blogged about numerous times here. (See links below). I’ll be back later with more to say about the article, but for now wanted to highlight the following quote from Debora Spar, the president of Barnard College and the author of The Baby Business, an excellent book on the assisted reproduction industry. Says Spar:
Our whole system makes no sense . . .We cap the price because of the yuck factor of commodifying human eggs, when we should either say, ‘Egg-selling is bad and we forbid it,’ as some countries do, or ‘Egg-selling is O.K., and the horse is out of the barn, but we’re going to regulate the market for safety.’
ASRM and SART also defend the compensation guidelines on the grounds that they prevent the undue influence and exploitation of egg donors. . . .
It is worth noting at the outset that many countries ban payments to egg donors entirely, due precisely to concerns such as these. Regardless of one’s views on the ultimate wisdom of such bans, they do possess a certain logic — if the lure of payment will cause women to donate who otherwise would not, then one possible solution is to ban payments. An attempt to address inducement concerns through price caps, however, is an entirely different matter.
- “Feeble Even By Normal Litigation Standards”
- Egg Donor Antitrust Suit In Today’s WSJ
- Sunny Samaritans’ Suit Survives
- ASRM Seeks Dismissal of Egg Donor Suit
- Kamakahi v. ASRM et al. — Updates
- Politics And Profits in The Egg Business (When Sunny Samaritans Sue, IV)
- When Sunny Samaritans Sue, Part III
- When Sunny Samaritans Sue, Continued
- When Sunny Samaritans Sue
- The Value of Smart Eggs